KalGene Pharmaceuticals Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.89M
Latest Deal Amount
  • Investors
  • 10

KalGene Pharmaceuticals General Information

Description

Developer of precision medicine therapeutics designed to slow the progression of Alzheimer's disease and cancer with an antibody-based approach. The company's therapeutics are aimed at improving clinical and survival efficacy through the use of personalized medicine to overcome safety issues, enabling physicians to alleviate patient suffering during treatment as well as improve the overall quality of life.

Contact Information

Website
www.kalgene.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • 945 Princess Street
  • Kingston, Ontario K7L 3N6
  • Canada
+1 (604) 000-0000

KalGene Pharmaceuticals Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

KalGene Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 22-Jun-2021 $2.89M 00.000 Completed Generating Revenue
5. Later Stage VC (Series A) 27-Nov-2017 00.000 00.000 Completed Generating Revenue
4. Accelerator/Incubator Completed Startup
3. Accelerator/Incubator 11-May-2016 Completed Startup
2. Grant 05-Jun-2015 $1.23M Completed Startup
1. Accelerator/Incubator Completed Startup
To view KalGene Pharmaceuticals’s complete valuation and funding history, request access »

KalGene Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of precision medicine therapeutics designed to slow the progression of Alzheimer's disease and cancer with an
Drug Discovery
Kingston, Canada
3 As of 2017
00.000
0000000000 0 00.000

0000000

la pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt moll
0000 000000000
Barcelona, Spain
00 As of 0000
000.00
000000000000 000.00

00000000

od tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercit
0000 000000000
Rye Brook, NY
00 As of 0000
000.00
0000000 0000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

KalGene Pharmaceuticals Competitors (26)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ability Pharma Venture Capital-Backed Barcelona, Spain 00 000.00 000000000000 000.00
00000000 Private Equity-Backed Rye Brook, NY 00 000.00 0000000 0000 000.00
00000000 000000000 Formerly VC-backed Boston, MA 00 00000 000000000 00000
000000 0000 000000 Corporation New York, NY 00 000.00 000000 - 000 000.00
000000 (0000 00000 Angel-Backed New York, NY 0 00000 0000000000 00000
You’re viewing 5 of 26 competitors. Get the full list »

KalGene Pharmaceuticals Executive Team (5)

Name Title Board Seat Contact Info
Nickolay Kukekov Ph.D President, Chief Executive Officer & Board Member
Sena Biswas Ph.D Interim Chief Executive Officer
T Nathan Yoganathan Ph.D President & Chief Scientific Officer
Anthony Giovinazzo Executive Chairman
You’re viewing 4 of 5 executive team members. Get the full list »

KalGene Pharmaceuticals Board Members (6)

Name Representing Role Since
Anthony Giovinazzo KalGene Pharmaceuticals Executive Chairman 000 0000
Benoit Cyr Self Board Member 000 0000
Daniel Hétu MD Lumira Ventures Board Member 000 0000
Jacki Jenuth Ph.D Lumira Ventures Chairperson 000 0000
James Callaway Ph.D KalGene Pharmaceuticals Board Member & Clinical Advisor 000 0000
You’re viewing 5 of 6 board members. Get the full list »

KalGene Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KalGene Pharmaceuticals Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accel-Rx Accelerator/Incubator Minority 000 0000 000000 0
Anges Québec Angel Group Minority 000 0000 000000 0
Anges Québec Capital Venture Capital Minority 000 0000 000000 0
Lumira Ventures Venture Capital Minority 000 0000 000000 0
JLABS Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »